Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Director/PDMR Shareholding - Replacement

8 Mar 2017 18:21

RNS Number : 9264Y
De La Rue PLC
08 March 2017
 

De La Rue plc

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

8 March 2017

De La Rue plc (the "Company") has been advised today by Equiom (Guernsey) Limited as Trustee of the De La Rue Employee Share Ownership Trust that on 7 March 2017, the Trustees made a market share purchase of 21,293 ordinary shares of 44 152/175p  in the capital of the Company, and on behalf of the Company, at a price of 625.5p per share, to satisfy the vesting of an award made to Martin Sutherland, Chief Executive Officer (for nil consideration), on 26 November 2014 and the subsequent sale of 10,028 of those shares at a price of 625.5p per share to cover tax and social security. The remainder of the shares (11,265) are being retained.

The notification below is provided in accordance with the requirements of the EU Market Abuse Regulations.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Martin Sutherland

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer (and PDMR)

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44 152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

(i) Vesting of 21,293 ordinary shares of an award made in November 2014; and (ii) the subsequent sale of sufficient shares to cover tax and social security. The remainder of the shares (11,265) are being retained.

c)

 

Price(s) and volume(s)

 

 

 

Transaction

Price(s)

 

Volume(s)

Total

Vesting

 

Nil

21,293

Nil

Sale for tax

625.5p

10,028

£62,725.14

 

 

d)

 

Aggregated information

 

 

Transaction

Price(s)

 

Volume(s)

Total

Vesting

 

Nil

21,293

Nil

Sale for tax

625.5p

10,028

£62,725.14

 

 

e)

 

Date of the transaction

 

2017-03-07 (GMT)

f)

 

Place of the transaction

 

(i) Vesting: Outside a trading venue

(ii) Sale: London Stock Exchange (XLON)

 

Ed Peppiatt, Company Secretary

Contact Number: 01256 605343

8 March 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSSAFAAFWSEFD
Date   Source Headline
13th Dec 20249:24 amRNSForm 8.5 (EPT/RI) - De La Rue plc
12th Dec 20243:36 pmRNSResponse to speculation
12th Dec 20247:00 amRNS2024/2025 HALF YEAR RESULTS
27th Nov 20247:00 amRNSNotice of Results
21st Nov 202412:52 pmRNSHolding(s) in Company
13th Nov 20249:00 amRNSAppointment of joint broker
1st Nov 20249:43 amRNSTotal Voting Rights
21st Oct 202410:03 amRNSHolding(s) in Company
15th Oct 20247:00 amRNSProposed sale of Authentication for £300m
25th Sep 20243:49 pmRNSAGM Statement, trading update & strategic update
9th Aug 20244:33 pmRNSNotice of AGM
1st Aug 202410:03 amRNSTotal Voting Rights
31st Jul 20242:07 pmRNSHolding(s) in Company
30th Jul 20243:39 pmRNSDirector/PDMR Shareholding
30th Jul 20243:32 pmRNSAnnual Financial Report
25th Jul 20247:00 amRNS2024 Full Year Results
9th Jul 20244:22 pmRNSDirector/PDMR Shareholding
1st Jul 202412:11 pmRNSBlock listing Interim Review
1st Jul 202412:05 pmRNSTotal Voting Rights
27th Jun 20243:48 pmRNSHolding(s) in Company
30th May 20247:00 amRNSStrategic Update
2nd May 202411:39 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSPre-Close Trading Statement
16th Apr 202411:52 amRNSHolding(s) in Company
16th Apr 202410:59 amRNSHolding(s) in Company
3rd Apr 20247:00 amRNSExtension of contract with Microsoft
2nd Apr 202411:25 amRNSTotal Voting Rights
7th Mar 20241:04 pmRNS2023 AGM Voting Update
23rd Feb 20242:06 pmRNSAdditional Listing
29th Jan 20244:14 pmRNSHolding(s) in Company
26th Jan 20244:38 pmRNSDirector/PDMR Shareholding
18th Jan 20243:19 pmRNSHolding(s) in Company
18th Jan 202412:13 pmRNSHolding(s) in Company
2nd Jan 202411:33 amRNSBlock listing Interim Review
21st Dec 20233:51 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNS2023/24 half year results
27th Nov 20232:53 pmRNSHolding(s) in Company
1st Nov 20231:51 pmRNSTotal Voting Rights
30th Oct 202311:05 amRNSHolding(s) in Company
13th Oct 202310:27 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSPre-close Trading Statement
2nd Oct 202311:47 amRNSTotal Voting Rights
20th Sep 202312:59 pmRNSDirector/PDMR Shareholding
13th Sep 20231:09 pmRNSHolding(s) in Company
7th Sep 20231:59 pmRNSResult of AGM
7th Sep 20237:00 amRNSAGM statement and trading update
4th Sep 202312:36 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
14th Aug 20233:30 pmRNSHolding(s) in Company
11th Aug 20232:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.